BONE BIOLOGICS CORPORATION (BBLGW) Operating cash flow 2016–2025
BONE BIOLOGICS CORPORATION (BBLGW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.7MFY2025 · since FY2016: -$7.3M → -$2.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.7M | +34.8% |
| FY2024 | -$4.1M | +56.8% |
| FY2023 | -$9.6M | -167.9% |
| FY2022 | -$3.6M | -190.3% |
| FY2021 | -$1.2M | -187.8% |
| FY2020 | -$426,933 | +86.9% |
| FY2019 | -$3.3M | +20.8% |
| FY2018 | -$4.1M | -23.3% |
| FY2017 | -$3.3M | +54.6% |
| FY2016 | -$7.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice